miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis
Abstract Despite the established benefits of long‐term endocrine therapy, women with hormone receptor‐positive breast cancer remain at risk for late relapse. The basis of this is multi‐factorial including genetic, epigenetic, and host factors. In this study we have explored the epigenetic regulation...
Main Authors: | Madhumathy G Nair, Jyothi S Prabhu, Aruna Korlimarla, Savitha Rajarajan, Hari P S, Roma Kaul, Annie Alexander, Rohini Raghavan, Srinath B S, Sridhar T S |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3183 |
Similar Items
-
Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes
by: Savitha Rajarajan, et al.
Published: (2021-06-01) -
WNT Signaling and Bone: Lessons From Skeletal Dysplasias and Disorders
by: Yentl Huybrechts, et al.
Published: (2020-04-01) -
Database for the Study of Biological Pathways, with Wnt Signaling Pathway Use Case
by: Mailavaram, Sravanthi
Published: (2009) -
Wnt9A Induction Linked to Suppression of Human Colorectal Cancer Cell Proliferation
by: Irshad Ali, et al.
Published: (2016-04-01) -
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers
by: Kamal Ahmed, et al.
Published: (2016-07-01)